CD8A and cancer: To challenge this suppression, DC production needs to be much more robust, and DC activity needs to be much better at activating the cytotoxic CD8+ T cells, which can immediately eliminate cancer cells to decrease the tumor burden and relieve the patient’s immune system from immunosuppression.